Inventor · disambiguated record
Peter Herrlich
Also filed as: HERRLICH PETER · HERRLICH PETER A
7 granted patents·8 pending applications·78 citations·filing 1991–2007
85Inventor score
Files withKERNFORSCHUNGSZ KARLSRUHE4BOEHRINGER INGELHEIM INT1G2M CANCER DRUGS AG1GEORG SPEYER HAUS1GEORG SPEYTER HAUS CHEMOTHERAP1
Top patents by PatentIndex Score
15 records- 0168US5951982AMethods to suppress an immune response with variant CD44-specific antibodiesKERNFORSCHUNGSZ KARLSRUHE·Filed 1994·Granted Sep 14, 1999·26 cites·6 claims
- 0266US5885575AAntibodies that react with variant CD44 surface proteinsKERNFORSCHUNGSZ KARLSRUHE·Filed 1995·Granted Mar 23, 1999·20 cites·12 claims
- 0362US7265154B2Valproic acid and derivatives thereof as histone deacetylase inhibitorsGEORG SPEYTER HAUS CHEMOTHERAP·Filed 2001·Granted Sep 4, 2007·6 cites·11 claims
- 0448US6010865AProcess for detecting a variant CD44 gene productBOEHRINGER INGELHEIM INT·Filed 1994·Granted Jan 4, 2000·17 cites·7 claims
- 0544US2007232696A1Valproic acid and derivatives thereof as histone deacetylase inhibitorsGEORG SPEYER HAUS·Filed 2007·Application pending·0 cites
- 0641US2006166287A1Method for Identifying compounds for suppressing metastasizing tumor cellsPONTA HELMUT·Filed 2003·Application pending·0 cites
- 0740US2002165153A1Transcription factors and their useFiled 2002·Application pending·0 cites
- 0839US5760178AHuman and rat variants of glycoprotein CD44 containing an additional extracellular domain associated with metastatic potentialKERNFORSCHUNGSZ KARLSRUHE·Filed 1995·Granted Jun 2, 1998·3 cites·3 claims
- 0938US5506119ADNA encoding variant CD44 surface proteins associated with metastatic tumorsKERNFORSCHUNGSZ KARLSRUHE·Filed 1991·Granted Apr 9, 1996·3 cites·5 claims
- 1037US2004265804A1Method for identifying metastatic tumor cellsVON STEIN OLIVER·Filed 2001·Application pending·0 cites
- 1136US2003172393A1Non-human transgenic mammal, method for producing same and its useFiled 2002·Application pending·0 cites
- 1235US2005038113A1Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual diseaseG2M CANCER DRUGS AG·Filed 2002·Application pending·0 cites
- 1330US6391301B1Agent for identifying and treating metastasizing tumorsKARLSRUHE FORSCHZENT·Filed 1997·Granted May 21, 2002·3 cites·5 claims
- 1429US2004072171A1Method for identifying compounds for modulating the activity of a tumor suppressor proteinFiled 2001·Application pending·0 cites
- 1524US2002160010A1Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactionsFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Herrlich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →